Guanylate binding protein-1-mediated epithelial barrier in human salivary gland duct epithelium
Guanylate binding protein-1-mediated epithelial barrier in human salivary gland duct epithelium
复制标题
DOI:
10.1016/j.yexcr.2018.07.033
复制
发表时间:
2018-10-01
影响因子:
3.7
通讯作者:
Kojima, Takashi
中科院分区:
文献类型:
--
作者:
Konno, Takumi;Takano, Kenichi;Kojima, Takashi
Guanylate-binding protein-1 (GBP-1) is an interferon-inducible large GTPase involved in the epithelial barrier at tight junctions. To investigate the role of GBP-1 in the epithelial barrier, primary human salivary gland duct epithelial cells were treated with the the proinflammatory cytokines IFN gamma, IL-1 beta, TNF alpha and the growth factor TGF-beta. Treatment with IFN gamma, IL-1 beta, or TNF alpha markedly enhanced GBP-1 and the epithelial barrier function, and induced not only CLDN-7 but also the tricellular tight junction molecule lipolysis-stimulated lipoprotein receptor (LSR). Knockdown of GBP-1 by its siRNA induced endocytosis of tight junction molecules, and prevented the increases of CLDN-7 and LSR with the upregulation of the epithelial barrier function induced by treatment with IFN gamma or TNF alpha. Treatment with a PKC alpha inhibitor induced expression of GBP-1, CLDN-7 and LSR and enhanced the epithelial barrier function. In almost intact salivary gland ducts from patients with IgG4-related disease (IgG4-RD) indicated significant infiltration of IgG-positive plasma cells, expression of GBP-1, CLDN-7 and LSR was increased. These findings indicated that GBP-1 might play a crucial role in barrier function of normal human salivary gland duct epithelium and perform a preventive role in the duct epithelium of IgG4-RD disease.